Frankfurt - Delayed Quote EUR

Gossamer Bio, Inc. (4GB.F)

0.7475

+0.0580

+(8.41%)

As of 9:59:01 AM GMT+2. Market Open.

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Simply Wall St. 2 days ago

GOSS
Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look at where Gossamer Bio Inc. (NASDAQ:GOSS) stands against other penny stocks to invest in under $1. Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, […]

Insider Monkey 7 days ago

GOSS
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]

Insider Monkey 14 days ago

GOSS
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 08, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board of Directors approved the grant, effective April 7, 2025, to one non-executive employee of non-qualified stock option a

Business Wire 15 days ago

GOSS
Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

We recently published a list of 12 Popular Penny Stocks on Robinhood to Watch. In this article, we are going to take a look at where Gossamer Bio Inc. (NASDAQ:GOSS) stands against other popular penny stocks on Robinhood to watch. The stock market is navigating a complex landscape influenced by geopolitical tensions, trade policies, and […]

Insider Monkey 27 days ago

GOSS

HOOD
Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other hot biotech stocks under $5. The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention. After a […]

Insider Monkey 28 days ago

GOSS
Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other penny stocks with the biggest upside potential. Penny stocks trade below $5 and attract investors looking for high returns with […]

Insider Monkey last month

GOSS
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) delivered earnings and revenue surprises of 11.76% and 19.63%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

GOSS
Gossamer Bio: Q4 Earnings Snapshot

On a per-share basis, the San Diego-based company said it had a loss of 15 cents. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

Associated Press Finance last month

GOSS
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

SAN DIEGO, March 13, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the fourth quarter and year ended December 31, 2024, and provided a business update.

Business Wire last month

GOSS
3 Promising Penny Stocks With Over $100M Market Cap

As the U.S. stock market faces a sell-off driven by concerns over tariffs and economic uncertainty, investors are increasingly looking for opportunities that can offer resilience and potential growth. Penny stocks, while often associated with risk due to their smaller size and less-established nature, still hold promise when they are backed by strong financials. In this article, we explore three penny stocks that exhibit solid balance sheets and the potential for long-term value creation...

Simply Wall St. last month

GOSS

SLRN

KNDI
With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Key Insights Significantly high institutional ownership implies Gossamer Bio's stock price is sensitive to their...

Simply Wall St. last month

GOSS
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Conference on February 18 & 19, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting com

GlobeNewswire 2 months ago

HGRAF

AEMD

GOSS
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

SAN DIEGO, February 03, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), presented one oral presentation and three posters related to seralutinib at the Pulmonary Vascular Research Institute (PVRI) 2025 Annual Congress that took place January 29th through Februar

Business Wire 2 months ago

GOSS
Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

As the U.S. stock market navigates a period of uncertainty marked by unchanged interest rates and looming big-tech earnings, investors are keenly observing potential opportunities in various sectors. Penny stocks, often associated with smaller or emerging companies, continue to capture attention due to their affordability and growth potential. Despite being considered a niche area today, these stocks can offer significant value when backed by strong financial health; we'll explore three such...

Simply Wall St. 2 months ago

VRA

MLSS

GOSS
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

SAN DIEGO, January 28, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced one oral and three poster presentations related to seralutinib at the Pulmonary Vascular Research Institute (PVRI) 2025 Annual Congress taking place January 29th through Febru

Business Wire 2 months ago

GOSS
Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other best penny stocks to buy according to the media. Small-Cap Stocks Outlook for 2025 On December 24, Global […]

Insider Monkey 3 months ago

GOSS

^RUT

^GSPC
3 US Penny Stocks With Market Caps Over $100M

As the U.S. stock market closes out a strong year on a weak note, with major indices posting significant gains despite recent downturns, investors are exploring diverse opportunities to balance their portfolios. Penny stocks, often representing smaller or newer companies, still hold potential for growth and value that larger firms might miss. In this article, we examine three penny stocks that stand out for their financial strength and potential to offer attractive returns in today's complex...

Simply Wall St. 3 months ago

RSSS

FPH

GOSS
Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks 3 months ago

GOSS
US Penny Stocks: 3 Picks With Market Caps Under $200M

As the S&P 500 and Nasdaq Composite reach record highs, driven by a surge in technology stocks, investors are increasingly exploring diverse opportunities across the market spectrum. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Simply Wall St. 4 months ago

GOSS

ME

GROV

Performance Overview

Return	4GB.F	S&P 500 (^GSPC)
YTD	-4.41%	-8.60%
1-Year	+9.77%	+6.00%
3-Year	-90.48%	+25.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Gossamer Bio, Inc. (4GB.F)

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

3 Promising Penny Stocks With Over $100M Market Cap

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

3 US Penny Stocks With Market Caps Over $100M

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

US Penny Stocks: 3 Picks With Market Caps Under $200M

Performance Overview